ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.

Prakash DeedwaniaPubMed ↗Publisher ↗

No numbers read from the abstract.